Drug Type Small molecule drug |
Synonyms RDG-17012 |
Target |
Action antagonists, inhibitors |
Mechanism F2R antagonists(Protease-activated receptor-1 antagonists), thrombin inhibitors(Factor IIa inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |





